Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

被引:144
作者
Miele, Luca [1 ]
Vallone, Selenia [2 ]
Cefalo, Consuelo [1 ]
La Torre, Giuseppe [5 ]
Di Stasi, Carmine [4 ]
Vecchio, Fabio M. [3 ]
D'Agostino, Magda [2 ]
Gabrieli, Maria L. [1 ]
Vero, Vittoria [1 ]
Biolato, Marco [1 ]
Pompili, Maurizio [1 ]
Gasbarrini, Giovanni [1 ]
Rapaccini, Gianludovico [1 ]
Amerio, Pierluigi [2 ]
De Simone, Clara [2 ]
Grieco, Antonio [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Internal Med, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Inst Dermatol, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Inst Pathol, I-00168 Rome, Italy
[4] Univ Cattolica Sacro Cuore, Inst Radiol, I-00168 Rome, Italy
[5] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy
关键词
NAFLD; Steatosis; Psoriatic arthritis; Methotrexate; Fibrosis; Liver function test; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; RISK-FACTORS; TNF-ALPHA; METHOTREXATE; STEATOHEPATITIS; EXPRESSION; FIBROSIS; PATHOGENESIS; ARTHRITIS;
D O I
10.1016/j.jhep.2009.06.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims:The association between NAFLD and psoriasis has never been explored in prospective epidemiological studies. The aim of this 2-phase study was to study the clinical features of NAFLD in patients with psoriasis. Methods: Phase 1: Investigation of prevalence and characteristics of NAFLD in an unselected cohort of 142 adult Italian outpatients with psoriasis vulgaris. Phase 2: Comparison of the psoriasis cohort subgroup with NAFLD and an age- and body mass index-matched retrospective cohort of 125 non-psoriasis patients with biopsy proven NAFLD. Results: Based on histories, laboratory tests, and ultrasound studies, 84 (59.2%,) received clinical diagnosis of NAFLD; 30 had factors potentially associated with liver disease other than NAFLD (e.g., viral hepatitis, significant ethanol, methotrexate use); and 28 (19.7%) had normal livers. Comparison of the normal-liver and NAFLD subgroups revealed that NAFLD in psoriasis patients (Ps-NAFLD) was significantly correlated with metabolic syndrome (p < 0.05); obesity (p = 0.043); hypercholesterolemia (p = 0.029); hypertriglyceridemia (p < 0.001); AST/ALT ratio >1 (p = 0.019), and psoriatic arthritis (PsA) (p = 0.036). The association with PsA remained significant after logistic regression analysis (OR = 3.94 [CI, 1.07-14.46]). Compared with the retrospective non-psoriatic NAFLD cohort (controls), Ps-NAFLD patients (cases) were likely to have severe NAFLD reflected by non-invasive NAFLD Fibrosis Scores and AST/ALT >1. Conclusions: NAFLD is highly prevalent among psoriasis patients, where it is closely associated with obesity (overall and abdominal), metabolic syndrome, and PsA, and more likely to cause severe liver fibrosis (compared with nonPs-NAFLD). Routine work-up for NAFLD may be warranted in patients with psoriasis, especially when potentially hepatotoxic drug therapy is being considered. (C) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:778 / 786
页数:9
相关论文
共 34 条
[1]   Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease [J].
Abdelmalek, Manal F. ;
Liu, Chen ;
Shuster, Jonathan ;
Nelson, David R. ;
Asal, Nabih R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (09) :1162-1169
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[4]  
[Anonymous], 1997, REPORT EXPERT COMMIT, V20, P1183
[5]   PSORIASIS - CLINICAL FEATURES [J].
BAKER, H .
BRITISH MEDICAL JOURNAL, 1971, 3 (5768) :231-&
[6]   Cytokine gene polymorphisms - Association with psorlatic arthritis susceptibility and severity [J].
Balding, J ;
Kane, D ;
Livingstone, W ;
Mynett-Johnson, L ;
Bresnihan, B ;
Smith, O ;
FitzGerald, O .
ARTHRITIS AND RHEUMATISM, 2003, 48 (05) :1408-1413
[7]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[8]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[9]   Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment [J].
Carter-Kent, Christine ;
Zein, Nizar N. ;
Feldstein, Ariel E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04) :1036-1042
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497